A University of Alberta research team has uncovered a new role for a genetic mutation previously known to be linked to developmental disorders—and it could hold the key to more effective treatments ...
CFOs are experimenting with AI use cases to free up capacity for business-critical work. In association withDeloitte Generative AI has the potential to transform the finance function. By taking on ...
Users of the online gaming platform Roblox in the UAE will temporarily be unable to chat in the game. The joint statement was made in a social media post by the Telecommunications and Digital ...
A new COPILOT function in Excel lets you use AI in a formula. The new skill is now available to Microsoft 365 insiders. Reduces some of the complexity involved in creating formulas. Get more in-depth ...
You can see it coming in right there, that little spot,” says neuroscientist and engineer Laura Lewis. A remarkably bright pulsing dot has appeared on the monitor in front of us. We are watching, in ...
A new study led by UC San Francisco researchers finds that chronic cannabis use — whether it’s smoked or consumed in edible form — is associated with significant cardiovascular risks. The report, ...
Function Health, a preventive health and longevity startup, acquired Ezra to integrate Function’s lab testing capabilities with the company’s artificial-intelligence-powered full-body scans, combining ...
Finance departments operate amid a constant stream of disruptions: talent scarcity, rapidly evolving technology, emerging environmental, social, and governance (ESG) standards. But no matter how many ...
It can be hard to think clearly after a bad night’s sleep. And, although nothing will replace a high-quality snooze, new research suggests taking a particular supplement may help you release some of ...
As a person with a chronic illness, I'm no stranger to bloodwork. I used to pore over my lab results, googling the various meanings, and trying not to panic when a test fell out of range. Function ...
Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results